Result Filters
Electronic prescribing of controlled substances and use of prescription drug monitoring programs among office-based physicians, 2019-2021
- Author(s):
- Richwine, Chelsea J, author
- Everson, Jordan, author
- United States Department of Health and Human Services Office of the National Coordinator for Health Information Technology, issuing body
- Title(s):
- Electronic prescribing of controlled substances and use of prescription drug monitoring programs among office-based physicians, 2019-2021 / Chelsea Richwine and Jordan Everson.
- Series:
- ONC data brief ; no. 63
- Country of Publication:
- United States
- Publisher:
- Washington, DC : Office of the National Coordinator for Health Information Technology, January 2023.
- Description:
- 1 online resource (1 PDF file (17 pages)) : illustrations.
-
Language:
- English
- Electronic Links:
- https://www.healthit.gov/sites/default/files/2023-01/Electronic%20Prescribing%20of%20Controlled%20Substances%20and%20Use%20of%20PDMP-Data-brief_508.pdf
http://resource.nlm.nih.gov/9918540679106676
- Summary:
- Electronic prescribing of controlled substances (EPCS) enables clinicians to securely transmit prescriptions for controlled substances to a pharmacy. Prescription drug monitoring programs (PDMPs) are electronic databases that contain patient-specific prescription information, which enables clinicians to view their patients’ prescription history before prescribing contolled substances. Together, the use of EPCS and PDMPs can help clinicians make informed treatment decisions. However, these tools are only useful if EPCS is used routintely, and if clinicians check the PDMP prior to prescribing. Recent efforts, such as federally mandated use of EPCS technology (3) and integration of PDMPs into electronic health record (EHR) systems, have aimed to increase the utility of information contained in PDMPs. This brief provides national estimates of office-based physicians’ use of EPCS and PDMPs in 2021 and explores variation in use by physician characteristics--including specialty, practice size, and frequency of prescribing controlled substances--and describes physician-reported benefits associated with PDMP use.
- MeSH:
- Controlled Substances*
Electronic Prescribing*
Practice Patterns, Physicians'*
Prescription Drug Monitoring Programs*
United States
- Publication Type(s):
- Technical Report
- Notes:
- Includes bibliographical references.
12 ref.
- Copyright Status:
- The National Library of Medicine believes this item to be in the public domain.
- NLM ID:
- 9918540679106676 [Electronic Resource]